CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Eric Ostertag

Founder and Former CEO, Poseida Therapeutics, Roche Holding AG

Search every verified Eric Ostertag interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Eric Ostertag, founder and former CEO of Poseida Therapeutics, discussed the company's work in CAR T-cell and gene therapies in a 2021 podcast interview. He described Poseida's three-tiered development and manufacturing platform, emphasizing its advantages over traditional viral vector technologies, including lower manufacturing costs, faster timelines, improved safety, and greater cargo capacity for delivering DNA. He noted that standard viral approaches, such as AAV, can be too expensive and time-consuming to produce under GMP regulations, and may lack sufficient capacity for larger therapeutic genes, such as those needed for conditions like hemophilia A. Ostertag also recounted the early history of CAR T therapy, citing the case of Emma Whitehead, the first pediatric patient treated with CAR T at the University of Pennsylvania, where Ostertag earned his M.D. and Ph.D. He credited his perseverance, which he said began when he convinced University of Pennsylvania department heads to license their technology to him despite lacking a CEO, as a common thread driving his entrepreneurial and company-building efforts.

Recent appearances

  • Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.

    September 27, 2021 · 📺 Life Science Connect

    Eric Ostertag, M.D., Ph.D., wanted to launch a biotech. When University of Pennsylvania department heads said no to a licensing deal for lack of a CEO, Dr. Ostertag convinced them he could run the company. Many bold moves later, Dr. Ostertag is founder and CEO at Poseida Therapeutics, a company that's doing things never seen before in the field of CAR T-cell and gene therapies for multiple myeloma and prostate cancer. On this week's episode of The Business of Biotech, Dr. Ostertag gives us a tour of the architecture supporting Poseida's unique 3-tiered development and manufacturing platform.…

    Watch on YouTube ↗

  • Using Gene Therapies to Fight Cancer and Tumor Cell Therapeutics - Discussion with Eric Ostertag

    June 25, 2021 · 📺 Finding Genius Podcast

    Our Website: https://www.findinggeniuspodcast.com/ Subscribe and review our Podcast on iTunes: https://apple.co/2L6tN88 Follow us on: Facebook:   / futuretechpodcast   Twitter:   / finding_genius   Instagram:   / findinggeniuspodcast   LinkedIn:   / finding-genius-podcast   How can cancer be treated differently than how many others have accepted as standard? Gene therapy may be the solution to change the course of cancer treatment. Listen in to learn: 1. The chances of getting cancer in your lifetime 2. How CAR-T therapy operates 3. How genetic therapies are limited CEO of Poseida Ther…

    Watch on YouTube ↗

  • #TradeTalks: The ultimate promise of cell and gene therapy

    February 16, 2021 · 📺 Nasdaq

    Poseida CEO Dr. Eric Ostertag joins Jill Malandrino on Nasdaq #TradeTalks to discuss the ultimate promise of cell and gene therapy for the treatment of cancers and genetic diseases, as well as infectious disease.

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →